Bumrungrad Hospital Public Company Limited (SET: BH) has announced its 2Q23 consolidated financial statement through the Stock Exchange of Thailand as follows;
| Quarter | 2Q23 | 2Q22 |
| Net Profit (Loss) Million Baht |
1,747,83 | 1,165,95 |
| Earning Per Share (Baht) |
2.20 | 1.47 |
| % Change | 49.9 | |
| 6 Months | 2023 | 2022 |
| Net Profit (Loss) Million Baht |
3,331,19 | 1,890,99 |
| Earning Per Share (Baht) | 4.19 | 2.38 |
| % Change | 76.2 | |
In 2Q23, BH reported a net profit of THB1,748 million, up 49.9% from THB1,166 million in 2Q22, net profit margin at 28.4%, compared to 23.5% in 2Q22.
Total revenues in 2Q23 was THB6,147 million, a 24.1% increase from THB4,954 million in 2Q22. Compared with 2Q19, in order to gauge the performance of the current quarter to pre-covid levels, 2Q23 total revenues and net profit increased by 42.7% and 141.1%, respectively, from 2Q19. Net profit margin rose to 28.4% in 2Q23, compared to 16.8% in 2Q19.
Revenues from hospital operations was THB6,029 million in 2Q23, a 23.0% increase YoY from THB4,903 million in 2Q22. This was mostly due to an increase in revenues from non-Thai patients and Thai patients by 28.6% and 13.7%, respectively. As a result, the revenue contribution from Thai patients was 34.8%, whereas revenue from non-Thai patients was 65.2% for 2Q23 compared with 37.7% and 62.3%, respectively, for 2Q22.
For the 6-month period, BH recorded a net profit of THB3,331 million, increasing by 76.2% from THB1,891 million in 1H22, with net profit margin at 27.2%, compared to 20.8% in 1H22.
Total revenues for 1H23 increased to THB12,235 million, or a 34.4% increase from THB9,106 million in 1H22. Compared with 1H19, 1H23 total revenues and net profit increased by 35.8% and 84.4%, respectively, from 1H19. Net profit margin rose to 27.2% in 1H23, compared to 20.1% in 1H19.
The Board of Directors approved a dividend payout of THB1.35 per share to be paid on September 6, 2023. The ex-dividend date is August 24, 2023.
